Browse diseases

…Background Despite recent advances, hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, part…

…n-based cancer vaccines offer a promising approach for treating solid tumors, but clinical efficacy has been limited by two major challenges…

…ton radiotherapy has emerged as a promising local treatment for hepatocellular carcinoma (HCC). This study examined the clinical outcomes of proton radi…

…ss B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. Nov 26 2020;6(1):92.Chen SMY, Krinsky AL,…

…Background CMS4 colorectal cancer features an immunosuppressive tumour microenvironment rich in c…

…enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat Med. 2023;29(6):1389–99.Ethics Approval This study was app…

…Introduction Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality wo…

…Background Hepatocellular carcinoma (HCC) is an aggressive liver cancer with poor prognosis. Deubiq…

…trium-90 (90Y) microspheres. This approach is currently used in hepatocellular carcinoma (HCC) treatment, which allows for the precise and targeted deli…

…to 0.32) and HCC (HR 0.03, 95% CI 0.01 to 0.21) in Group 1, and cirrhosis (HR 0.50, 95% CI 0.41 to 0.61) and HCC (HR 0.25, 95% CI 0.16 to…

…s like head and neck lung cancers, hepatocellular carcinoma and renal cell carcinoma. We have some encouraging data from our centre, as well as from…

…n (ICI) has become a first-line treatment strategy for advanced hepatocellular carcinoma (HCC). However, treatment efficacy remains varied, and there ar…